be_ixf;ym_202010 d_29; ct_50

Select Page

Latest Insights on MYL

Hydrogen, taxes … and Dodd-Frank? What? Hey, it’s Reader Feedback day at Great Stuff; you never know what you’re going to get. Hydrogen: 3 Stocks for an $11 Trillion Market
by Joseph Hargett October 1, 2020 Great Stuff
Hydrogen: It’s a Gas, Gas, Gas! Welcome to Reader Feedback day! As usual, today is all about you, dear reader! Your questions. Your concerns. Your interestingly worded rants and lyrical requests … the works. So sit back, relax and enjoy the show. Oh, and if you haven’t written in yet, now’s your chance! Drop the […]
wall street doesnt know Wall Street Forgot 2 Stocks — Profit From Its Mistake Wall Street simply forgot some stocks. And that provides us an opportunity. There are some solid, low-risk deals out there.
I can’t believe that I — the guy making financial memes— had to be the one to sound the warning, but that’s where we are in this market. Apple Is the Canary; Buffett Goes Kroger-ing
by Joseph Hargett February 18, 2020 Great Stuff
COVID-19: Greater Than Just Apple Oh man … what a weekend! (There ain’t no party like a Presidents Day party. Am I right?) But it wasn’t all George-cherry Jell-O shots and Abe appletinis… In this midst of consuming my executive branch libations, I was struck with a thought: What would it take for Wall Street […]
Great Stuff 7-29-2019 The IRS Is Coming for Your Bitcoin Profits
by Joseph Hargett July 29, 2019 Great Stuff
Fear and Follies on Wall Street We’ve got an interesting week ahead of us. Between a potential Federal Reserve rate cut, Democrats running for president and the IRS going after bitcoin profits, we’ll either be laughing or crying by Friday. Tomorrow, the Federal Reserve begins its two-day meeting to decide how to screw up — […]
There hasn’t been a new Alzheimer’s treatment in 16 years, with Big Pharma logging hundreds of dismal drug failures. But a new way of treating Alzheimer’s disease is showing great promise, offering great opportunity for individuals at risk and biotech investors alike. Investing in Alzheimer’s Disease Treatment Stocks There hasn’t been a new Alzheimer’s treatment in 16 years, with Big Pharma logging hundreds of dismal drug failures. But a new way of treating Alzheimer’s disease is showing great promise, offering great opportunity for individuals at risk and biotech investors alike.

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

I am up $20,070 in closed positions from Feb. 18 through March 7.

- Bob Rowe

I started your system in December … I am ahead $29,000 … I put total faith in you and your system and it has worked for me very nicely. Thanks again I sure like your humble approach about this whole thing

- Dale Leiffer

I have made a little over $4,000 while being cautious.

- Chuck Goss

Share This